Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology(2025)10.1002/1878-0261.70062Source: DataRank Database

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer is a research paper published in Molecular Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.48)OA: goldTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Anna M. Reagan,Charles J. Bailey ORCID,Mei Gao ORCID,Muqiang Gao ORCID,Angelica L. Solomon ORCID

Live enrichment

PubMed:40434951 PMC:PMC12515709 OpenAlex:https://openalex.org/W4410811876

Center for Scientific Review

Grant: T32CA160003

NCI NIH HHS

Grant: P30 CA177558

National Institutes of Health

Grant: 5T32CA160003-03

Oncology Research Training for Surgeon-Scientists

FWCI

0.48

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.70062

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.70062

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.70062

journalhttps://doi.org/10.1002/1878-0261.70062

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40434951

Fields of Study

Pancreatic and Hepatic Oncology ResearchNeuroendocrine Tumor Research AdvancesCancer Immunotherapy and Biomarkers03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsFemaleHumansPancreatic NeoplasmsCarcinoma, Pancreatic DuctalXenograft Model Antitumor AssaysCell Line, TumorMiceReceptors, CCRTumor MicroenvironmentAntibodies, Monoclonal, Humanized

Keywords

CytotoxicityPancreatic cancerCancer researchImmune systemCytotoxic T cellMonoclonal antibodyImmunotherapyChemokine receptorChemokineImmune checkpointHumanized mouseImmunologyAntibodyTumor microenvironmentMedicineCancerBiologyIn vitroInternal medicineChemokine Receptor Ccr9Antibodies, Monoclonal, HumanizedXenograft Model Antitumor AssaysPancreatic NeoplasmsReceptors, CCRMiceCell Line, TumorHumansAnimalsFemaleResearch ArticleCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 0: Good health and well-being

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

FAIR Checklist

Authors (19)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)